The Pfizer-BioNTech coronavirus vaccine is slightly less effective but still appears to offer protection against variant first detected in India, according to a study by France's Pasteur Institute.

Pfizer less effective, AstraZeneca even worse against variant first detected in India: Study

Europe's drug regulator has approved the Pfizer vaccine for children aged between 12 to 15 years old. Now this is a significant step in protecting children from future waves of COVID.

Coronavirus Update: European Union backs Pfizer jab for 12-15-year-old

The government is examining Pfizer's request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) V K Paul said on Thursday.

Central government examining Pfizer's request for indemnity, will take decision on merit: VK Paul

Pfizer is ready to send 50 million doses to India by July this year. But, it wants significant regulatory relaxations from India. What are Pfizer's demands? Palki Sharma brings you a report.

Gravitas: What Pfizer wants from India

Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant found in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.

Our vaccine highly effective on COVID-19 variant found in India, suitable for 12 yrs and above: Pfizer to Govt

Moderna is in talks with Cipla and other Indian pharma firms to launch its single-dose COVID-19 vaccine in India by the year 2022. Meanwhile, Pfizer has reportedly indicated that it can provide 5 crore doses of its vaccine this year.

Report: India may get single-dose Moderna COVID-19 vaccine by 2022

Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 50 million shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday.

Moderna's single-dose vaccine in India likely next year; Pfizer ready with 50 mn doses for 2021

Why can't India get vaccines from Pfizer and Moderna? Big Pharma firms say they want to negotiate directly with the Central government and set the terms. Some demands go beyond money. Palki Sharma tells you more.

Gravitas: Why can't India get COVID vaccines from Pfizer and Moderna?

When the Indian government allowed states to pursue their own vaccine procurement, the idea was welcomed. States governments were quick to seize the moment. Some chief ministers announced global tenders to buy shots from the international market.

Pfizer and Moderna don't want to deal with Indian states for vaccines

Indian government and Pfizer are at loggerheads over a demand by the US drug maker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets.

Indian Govt & Pfizer at loggerheads over COVID-19 vaccine indemnity demand

Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, have been vocal in their view that the world will soon need COVID-19 booster shots to maintain high levels of immunity.

Are we really in need of COVID-19 booster shots?

A new British study has found that Pfizer COVID-19 vaccine is more effective if the second dose is delayed to 12-weeks after the first. The study, which has not yet been peer reviewed—found that delaying the second dose to 12 weeks led to an antibody response that was three-and-half times larger than when vaccine doses were kept to the standard recommendation of three weeks apart

Study: Pfizer COVID-19 vaccine doses more effective with a 12-week gap

The European Union is ditching the AstraZeneca vaccine for the Pfizer shot. The bloc hasn't placed new orders for the Oxford vaccine beyond June. Palki Sharma tells you why.

Gravitas: European Union ditches AstraZeneca

Individuals who receive a single dose of the AstraZeneca vaccine have approximately 80% lower risk of death with COVID-19 compared with unvaccinated people, according to a new Public Health England (PHE) analysis.

One AstraZeneca Covid vaccine dose cuts death risk by 80%, 2 Pfizer doses by 97%: UK agency

Sri Lanka has now become the first South Asian nation to approve Pfizer COVID-19 vaccine. Sri Lanka to order 5 Million Pfizer doses.

Coronavirus Update: Sri Lanka to order 5 Million Pfizer doses

Doctors and nurses with fang stickers on their scrubs are offering free Pfizer shots to all-comers at 14th century Bran Castle, which is purported to be an inspiration for the vampire's towering home in Bram Stoker’s novel "Dracula".

COVID-19: 'Dracula's Castle' offers tourists COVID shots

The European Union has concluded deal for upto 1.8 billion extra doses of Pfizer/BioNTech Covid vaccine. European Commission chief Ursula von der Leyen made the announcement on Twitter as she attended an EU summit in Portugal.

EU seals deal for more 1.8 billion Pfizer/BioNTech Covid vaccine doses

Sri Lanka on Saturday approved Pfizer's COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India.

Sri Lanka approves Pfizer COVID vaccine for emergency use

Pharma giants Pfizer and BioNTech said on Friday that they were seeking approval for use of their vaccines for individuals aged 16 and above. The companies are planning to submi data to support application "on a rolling basis over the coming weeks" to US Food and Drug Administration (FDA), they said in a press release.

Pfizer, BioNTech seek approval for Covid vaccine for teens

Canada has authorised the use of the Pfizer COVID-19 vaccine for children between the ages of 12 and older. It is the first country to do so for this age group. The country's health ministry made the decision based on data from phase three clinical trials on children.

Canada authorises Pfizer COVID-19 vaccine for kids age 12 and older

When new inventions emerge, divides within society become more apparent. For instance, the television or the cell phone was owned only by a select few. The same thing is now happening with vaccines.

COVID-19: Why India is Pfizer's shot at redemption

The largest study on the Pfizer-BioNTech coronavirus vaccine so far has found that the drug provided more than 95 per cent protection against the deadly virus, but these numbers significantly drop when only one of the two prescribed doses are taken.

Largest study on Pfizer Covid vaccine says drug offers over 95% protection

Pfizer reported $3.5 billion in revenue from the sale of its covid vaccine in Q1. But most of these sales have targeted the richer countries. With an openly declared intention to churn profits, has Pfizer become the rich man's jab?

Gravitas: Pfizer's bumper profit from vaccine sales

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher COVID-19 vaccine sales as it targets the inoculations as a "durable" revenue stream.

Pfizer raises 2021 sales forecast for Covid vaccines to $26 billion

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news